TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills November 8, 2002